IVERIC bio (ISEE) Reports Q4 Loss of $0.39/Share

IVERIC bio (NASDAQ: ISEE) reported Q4 EPS of ($0.39), versus $2.62 reported last year.

For earnings history and earnings-related data on IVERIC bio (ISEE) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Boost Run posts Q2 revenue of $31.1M, up 270% year over year
• Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c